Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07040592 · ClinicalTrials.gov registry record · Phase 2

Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide

A Phase 2 study of HIV and Alcohol Use Disorder (AUD), sponsored by Yale University.

Recruiting
Registry status
Phase 2
Development phase
30
Enrollment target
1
Study location

NCT07040592 is a Phase 2 study of HIV and Alcohol Use Disorder (AUD) that is actively recruiting participants, run by Yale University. The registered enrollment target is 30 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07040592, a Phase 2 study of HIV and Alcohol Use Disorder (AUD), is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
Phase 2
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study seeks to determine the feasibility, acceptability, and preliminary efficacy of an intervention consisting of off-label use of a medication with strong efficacy data for alcohol use disorder (AUD) with medical management and a clinical pharmacist-delivered behavioral intervention in reducing alcohol use among individuals with HIV and AUD.

Conditions Studied

HIV Alcohol Use Disorder (AUD)

Interventions

  • DRUG semaglutide

Study Locations (1)

Georgia

  • Atlanta VA Medical Center - Decatur

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2026-01-15
Est. Completion 2027-06-30
Phase Phase 2

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07040592

The ClinicalTrials.gov registry entry for NCT07040592 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (93% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which semaglutide is the first listed.

NCT07040592 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT07040592 about?

NCT07040592 is a clinical study titled "Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide". This study seeks to determine the feasibility, acceptability, and preliminary efficacy of an intervention consisting of off-label use of a medication with strong efficacy data for alcohol use disorder (AUD) with medical management and a clinical pharmacist-delivered behavioral intervention in reduci...

What is the current status of trial NCT07040592?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2026-01-15. Estimated completion is 2027-06-30.

What conditions does trial NCT07040592 study?

This clinical trial studies the following conditions: HIV, Alcohol Use Disorder (AUD).

What interventions are being tested in trial NCT07040592?

The interventions under investigation include: semaglutide (DRUG).

Who is sponsoring clinical trial NCT07040592?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07040592 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV

All registered trials for this condition

Alcohol Use Disorder (AUD)

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.